Effects of adenoviral-mediated gene transduction of NK4 on proliferation. movement, and invasion of human colonic LS174T cancer cells in vitro

World Journal of Gastroenterology

Volumn 12, Issue 25, 2006, Pages 3983-3988

  Jie, Jian Zheng ^a,b   Wang, Jian Wei ^a,c   Qu, Jian Guo ^a   Wang, Wei ^b   Hung, Tao ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b JILIN UNIVERSITY   (China)

^c INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

Adenoviral vector; Hepatocyte growth factor; Human colonic adenocarcinoma; NK4

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; PROTEIN NK4; SCATTER FACTOR; UNCLASSIFIED DRUG;

ARTICLE; ATTENUATION; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER THERAPY; CELL INVASION; CELL MOTION; CELL PROLIFERATION; COLON ADENOCARCINOMA; COLON CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; STATISTICAL SIGNIFICANCE; VIRUS INFECTION; VIRUS RECOMBINANT;

EID: 33746238304     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i25.3983     Document Type: Article

References (35)

1. Matsumoto K, Nakamura T. HGF-c-Met receptor pathway in tumor invasion-metastasis and potential cancer treatment with NK4. In: Jiang WG, Matsumoto K, Nakamura T, ed. Growth factors and their receptors in cancer metastasis. Dordrecht: Kluwer Academic Publisher, 2001: 241-276
2. Jiang W, Hiscox S, Matsumoto K, Nakamura T. Hepatocyte growth factor/ scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 1999; 29: 209-248
3. Stuart KA, Riordan SM, Lidder S, Crostella L, Williams R, Skouteris GG. Hepatocyte growth factor/scatter factor-induced intracellular signalling. Int J Exp Pathol 2000; 81: 17-30
4. Stella MC, Comoglio PM. HGF: a multifunctional growth factor controlling cell scattering. Int J Biochem Cell Biol 1999; 31: 1357-1362
5. van der Voort R, Taher TE, Derksen PW, Spaargaren M, van der Neut R, Pals ST. The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation. Adv Cancer Res 2000; 79: 39-90
6. Jeffers M, Rong S, Woude GF. Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med 1996; 74: 505-513
7. Longati P, Comoglio PM, Bardelli A. Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene. Curr Drug Targets 2001; 2: 41-55
8. Date K, Matsumoto K, Shimura H, Tanaka M, Nakamura T. HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett 1997; 420: 1-6
9. Haddad R, Lipson KE, Webb CP. Hepatocyte growth factor expression in human cancer and therapy with specific inhibitors. Anticancer Res 2001; 21: 4243-4252
10. Matsumoto K, Nakamura T. Mechanisms and significance of bifunctional NK4 in cancer treatment. Biochem Biophys Res Commun 2005; 333: 316-327
11. Jie JZ, Wang JW, Wang W, Jiang XL, Wei Q, Hung T. Expression and characterization of HGF mutant NK4 in adenovirus vector. Zhongguo Shiyan Zhenduanxue 2003; 7: 397-400
12. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998; 280: 1614-1617
13. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-3245
14. Calaluce R, Miedema BW, Yesus YW. Micrometastasis in colorectal carcinoma: a review. J Surg Oncol 1998; 67: 194-202
15. Birchmeier C, Birchmeier W. Molecular aspects of mesenchymal-epithelial interactions. Annu Rev Cell Biol 1993; 9: 511-540
16. Sakakura T. New aspects of stroma-parenchyma relations in mammary gland differentiation. Int Rev Cytol 1991; 125: 165-202
17. Hu M, Pollock RE, Nakamura T, Nicolson GL. Human peritumoral and lung fibroblasts produce paracrine motility factors for recently established human sarcoma cell strains. Int J Cancer 1995; 62: 585-592
18. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-1459
19. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-443
20. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995; 129: 1177-1180
21. Vande Woude GF, Jeffers M, Cortner J, Alvord G, Tsarfaty I, Resau J. Met-HGF/SF: tumorigenesis, invasion and metastasis. Ciba Found Symp 1997; 212: 119-130; discussion 130-132, 148-154
22. Stella MC, Comoglio PM. HGF: a multifunctional growth factor controlling cell scattering. Int J Biochem Cell Biol 1999; 31: 1357-1362
23. Matsumoto K, Nakamura T. NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics. Cancer Sci 2003; 94: 321-327
24. Maemondo M, Narumi K, Saijo Y, Usui K, Tahara M, Tazawa R, Hagiwara K, Matsumoto K, Nakamura T, Nukiwa T. Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy. Mol Ther 2002; 5: 177-185
25. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gagha P, Zara P, Comoglio PM. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 1991; 6: 1997-2003
26. Kaji M, Yonemura Y, Harada S, Liu X, Terada I, Yamamoto H. Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells. Cancer Gene Ther 1996; 3: 393-404
27. Maehara N, Matsumoto K, Kuba K, Mizumoto K, Tanaka M, Nakamura T. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells. Br J Cancer 2001; 84: 864-873
28. Kubota T, Fujiwara H, Amaike H, Takashima K, Inada S, Atsuji K, Yoshimura M, Matsumoto K, Nakamura T, Yamagishi H. Reduced HGF expression in subcutaneous CT26 tumor genetically modified to secrete NK4 and its possible relation with antitumor effects. Cancer Sci 2004; 95: 321-327
29. Saimura M, Nagai E, Mizumoto K, Maehara N, Okino H, Katano M, Matsumoto K, Nakamura T, Narumi K, Nukiwa T, Tanaka M. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice. Cancer Gene Ther 2002; 9: 799-806
30. Grimstad IA. Direct evidence that cancer cell locomotion contributes importantly to invasion. Exp Cell Res 1987; 173: 515-523
31. Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995; 55: 1856-1862
32. Parr C, Hiscox S, Nakamura T, Matsumoto K, Jiang WG. Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells. Int J Cancer 2000; 85: 563-570
33. Ramanujan S, Koenig GC, Padera TP, Stoll BR, Jain RK. Local imbalance of proangiogenic and antiangiogenic factors: a potential mechanism of focal necrosis and dormancy in tumors. Cancer Res 2000; 60: 1442-1448
34. Ueda K, Iwahashi M, Matsuura I, Nakamori M, Nakamura M, Ojima T, Naka T, Ishida K, Matsumoto K, Nakamura T, Yamaue H. Adenoviral-mediated gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice. Eur J Cancer 2004; 40: 2135-2142
35. Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model. Diabetologia 2003; 46: 115-123